Progress with covalent small-molecule kinase inhibitors

被引：142
|
作者：
Zhao, Zheng [1 ]
Bourne, Philip E. [1 ]
机构：
[1] Univ Virginia, Dept Biomed Engn, Charlottesville, VA 22908 USA
来源：
DRUG DISCOVERY TODAY | 2018年 / 23卷 / 03期
关键词：
CELL LUNG-CANCER; ATP-BINDING SITE; IRREVERSIBLE INHIBITORS; PROTEIN-KINASES; DRUG DISCOVERY; TYROSINE KINASE; TREATMENT STRATEGIES; EGFR INHIBITORS; HUMAN KINOME; RESISTANCE;
D O I：
10.1016/j.drudis.2018.01.035
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
With reduced risk of toxicity and high selectivity, covalent small-molecule kinase inhibitors (CSKIs) have emerged rapidly. Through the lens of structural system pharmacology, here we review this rapid progress by considering design strategies and the challenges and opportunities offered by current CSKIs.
引用
收藏
页码：727 / 735
页数：9
相关论文
共 50 条
  • [31] Small-molecule enzyme inhibitors
    Edwards, P
    [J]. DRUG DISCOVERY TODAY, 2001, 6 (03) : 160 - 160
  • [32] Recent progress in small-molecule inhibitors for critical therapeutic targets of necroptosis
    Fang, Zhennan
    Wei, Huiqiang
    Gou, Wenfeng
    Chen, Leyuan
    Bi, Changfen
    Hou, Wenbin
    Li, Yiliang
    [J]. FUTURE MEDICINAL CHEMISTRY, 2021, 13 (09) : 817 - 838
  • [33] Progress in small-molecule inhibitors targeting PD-L1
    Xu, Jindan
    Kong, Yuanfang
    Zhu, Pengbo
    Du, Mingyan
    Liang, Xuan
    Tong, Yan
    Li, Xiaofei
    Dong, Chunhong
    [J]. RSC MEDICINAL CHEMISTRY, 2024, 15 (04): : 1161 - 1175
  • [34] Kinase-targeting small-molecule inhibitors and emerging bifunctional molecules
    Goebel, Georg L.
    Qiu, Xiaqiu
    Wu, Peng
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2022, 43 (10) : 866 - 881
  • [35] Small-molecule kinase inhibitors: an analysis of FDA-approved drugs
    Wu, Peng
    Nielsen, Thomas E.
    Clausen, Mads H.
    [J]. DRUG DISCOVERY TODAY, 2016, 21 (01) : 5 - 10
  • [36] Cutaneous toxicity of FDA-approved small-molecule kinase inhibitors
    Du, Jiangxia
    Yan, Hao
    Xu, Zhifei
    Yang, Bo
    He, Qiaojun
    Wang, Xiaohong
    Luo, Peihua
    [J]. EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2021, 17 (11) : 1311 - 1325
  • [37] Identification and characterization of small-molecule inhibitors of Tie2 kinase
    Liu, Jinqi
    Lin, Tsung H.
    Cole, Andrew G.
    Wen, Rong
    Zhao, Lian
    Brescia, Marc-Raleigh
    Jacob, Biji
    Hussain, Zahid
    Appell, Kenneth C.
    Henderson, Ian
    Webb, Maria L.
    [J]. FEBS LETTERS, 2008, 582 (05) : 785 - 791
  • [38] Prediction of specificity-determining residues for small-molecule kinase inhibitors
    Daniel R Caffrey
    Elizabeth A Lunney
    Deborah J Moshinsky
    [J]. BMC Bioinformatics, 9
  • [39] Small-molecule inhibitors for targeting polo-like kinase 1
    Kolosenko, Iryna
    Palm-Apergi, Caroline
    [J]. FUTURE MEDICINAL CHEMISTRY, 2020, 12 (16) : 1457 - 1460
  • [40] Targeted Small-Molecule Inhibitors of Protein Kinase B as Anticancer Agents
    Collins, Ian
    [J]. ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2009, 9 (01) : 32 - 50
12345